Abstract:Here, we present combined experimental and theoretical studies on the spectroelectrochemical properties of 8-aminoquinoline (8AQ). 8AQ is a model molecule for drugs that can chelate copper(II) ions, and thus it may find applications in halting the development of Alzheimer’s disease. Although over a hundred years have passed since Alzheimer’s disease (AD) was first described, it remains incurable to this day. According to one of the leading hypotheses, peptides from the β-amyloid (Aβ) group are responsible for the development of AD. By binding copper(II) ions, Aβs form complexes whose presence promotes the formation of harmful, highly active compounds called reactive oxygen species (ROS) and reactive nitrogen species (RNS). In a series of recent studies, we investigated the differences in electrochemical properties of Cu(II)-complexes with the amyloids Aβ(11-16) and Aβ(3-16) with their pyroglutamated versions, pAβ(11-16) and pAβ(3-16). [1,2] These results showed that the pyroglutamate amyloids are conducive to Cu(II)-reduction at a potential associated with ROS production. Given the abundance of pyroglutamated amyloids in senile plaques, this could have important consequences for AD pathophysiology. Overproduction of ROS and RNS can cause neuron death. Therefore, substances that can aid in removing copper(II) ions from β-amyloids could block the formation of ROS and RNS. Recently, a new quinoline derivative with unique properties has undergone preclinical studies. However, little is known about the redox properties of such molecules, which may be crucial in the early stages of testing potential therapeutic substances. Therefore, we aimed to perform electrochemical and spectroelectrochemical studies of a model molecule, 8-aminoquinoline, whose redox properties were not yet well characterized To fully characterize both anodic and cathodic processes, we used cyclic and pulse voltammetry over a wide range of pH values, including physiological (pH=7.4). In addition, the experimental results were supported by DFT-based computational studies exploring the energy landscapes of the possible reactions and advancing understanding of the electrochemical phenomena. The kind of electrochemical tests presented here may prove of crucial importance for the development of more effective drugs against AD. The high failure rate and relatively poor performance of the recently approved treatment indicates the need to extend preclinical studies with new, so far unused techniques, allowing a more complete picture to be obtained of the effectiveness and toxicity of the potential drug candidates. [1] M.Z. Wiloch, N. Baran, M. Jönsson‐Niedziółka, The Influence of Coordination Mode on the Redox Properties of Copper Complexes with Aβ(3‐16) and Its Pyroglutamate Counterpart pAβ(3‐16), ChemElectroChem. 9 (2022). https://doi.org/10.1002/celc.202200623. [2] M.Z. Wiloch, M. Jönsson-Niedziółka, Very small changes in the peptide sequence alter the redox properties of Aβ(11–16)-Cu(II) and pAβ(11–16)-Cu(II) β-amyloid complexes, Journal of Electroanalytical Chemistry. 922 (2022) 116746. https://doi.org/10.1016/j.jelechem.2022.116746.

Synthesis and evaluation of 8-hydroxyquinolin derivatives substituted with (benzo[d][1,2]selenazol-3(2H)-one) as effective inhibitor of metal-induced Aβ aggregation and antioxidant.

Design, Synthesis and Biological Evaluation of 2-Styryl-5-hydroxy-4-pyrone Derivatives and Analogues As Multiple Functional Agents with the Potential for the Treatment of Alzheimer's Disease.

Design, Synthesis, and Evaluation of Multitarget-Directed Selenium-Containing Clioquinol Derivatives for the Treatment of Alzheimer'S Disease

Synthesis and Biological Evaluation of Deferiprone-Resveratrol Hybrids As Antioxidants, Aβ1–42 Aggregation Inhibitors and Metal-Chelating Agents for Alzheimer's Disease

Synthesis and bio-activities of bifunctional tetrahydrosalen Cu (II) chelators with potential efficacy in Alzheimer's disease therapy

Synthesis and biological evaluation of novel 8- substituted sampangine derivatives as potent inhibitor of Zn2+-Aβ complex mediated toxicity, oxidative stress and inflammation

Novel 1-phenyl-3-hydroxy-4-pyridinone derivatives as Multifunctional Agents for the therapy of Alzheimer's Disease.

Spectroelectrochemical and Computational Study of Quinoline Based Molecules - Potential Anti-Alzheimer’s Drugs

Novel sampangine derivatives as potent inhibitors of Cu2+-mediated amyloid-β protein aggregation, oxidative stress and inflammation

Discovery of Quinolinone Hybrids as Dual Inhibitors of Acetylcholinesterase and Aβ Aggregation for Alzheimer's Disease Therapy

Novel coumarin derivatives as multifunctional anti-AD agents: Design, synthesis, X-ray crystal structure and biological evaluation

Sulfur-bridging the gap: investigating the electrochemistry of novel copper chelating agents for Alzheimer's disease applications

Discovery of novel melatonin–mydroxyquinoline hybrids as multitarget strategies for Alzheimer's disease therapy

New Multi-Target-directed Small Molecules Against Alzheimer's Disease: a Combination of Resveratrol and Clioquinol.

Multitarget-directed Benzylideneindanone Derivatives: Anti-Β-amyloid (aβ) Aggregation, Antioxidant, Metal Chelation, and Monoamine Oxidase B (MAO-B) Inhibition Properties Against Alzheimer's Disease.

Synthesis and investigation of the cholinesterase inhibitory and antioxidant capacities of some novel N'‐(quinolin‐4‐ylmethylene)propanehydrazides against Alzheimer's disease

Ionophoric polyphenols selectively bind Cu(2+), display potent antioxidant and anti-amyloidogenic properties, and are non-toxic toward Tetrahymena thermophila

Large Amino Acid Mimicking Selenium-Doped Carbon Quantum Dots for Multi-Target Therapy of Alzheimer’s Disease

Palladium-catalyzed synthesis and anti-AD biological activity evaluation of N-aryl-debenzeyldonepezil analogues

Silicon-Carbon Dots-Loaded Mesoporous Silica Nanocomposites (mSiO2@SiCDs): An Efficient Dual Inhibitor of Cu2+-Mediated Oxidative Stress and Aβ Aggregation for Alzheimer's Disease.

Novel inhibitors of AChE and Aβ aggregation with neuroprotective properties as lead compounds for the treatment of Alzheimer's disease